The largest database of trusted experimental protocols

6 protocols using molecular imager versadoc mp 4000

1

Western Blot Analysis of LC3 and G6PD

Check if the same lab product or an alternative is used in the 5 most similar protocols
1.5 × 106 cells (2008-C13) were plated in 100 mm cell culture dish and allowed to attach overnight. After 48 hours, cells were lysed with ice-cold lysis buffer supplemented with the protease inhibitor cocktails (Roche Molecular Biochemicals, Mannheim, Germany). The protein content was determined by Lowry procedure (Bio-rad DC Protein Assay, MA, USA). Equal amounts of protein (40 μg) were loaded on a polyacrylamide gel and electrophoretically separated in running buffer. After electrophoresis, the proteins were blotted onto an Hybond-P PVDF membrane (Amersham Biosciences, Buckinghamshire, UK). After blocking, the membrane was exposed to the elected primary antibodies: anti-LC3 (1:1000; Cell Signaling, MA, USA) or anti-G6PD (1:500; Santa Cruz Biotechnology, Inc., Europe). After washing, the membrane was incubated with HRP-conjugated anti-rabbit secondary antibody (1:3500; PerkinElmer, MA, USA). The signal was visualized with enhanced chemoluminescent kit (Amersham Biosciences) according to the manufacturer's instructions and analyzed by Molecular Imager VersaDoc MP 4000 (Bio-rad). LC3 and G6PD were normalized to beta-actin (1:7000; AbCam, Cambridge, UK).
+ Open protocol
+ Expand
2

Western Blot Analysis of Mitochondrial Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Lowry method was used to evaluate the protein content after the cells had been seeded in 6-well plates, cultured in complete media, and lysed using ice-cold lysis buffer supplemented with protease inhibitor cocktails (Roche Molecular Biochemicals, Mannheim, Germany) (Biorad DC Protein Assay, MA, USA). In the running buffer, 25 µg of protein from each sample was placed onto a polyacrylamide gel and electrophoretically separated. The proteins were blotted onto a Hybond-P PVDF membrane following electrophoresis (Amersham Biosciences, Buckinghamshire, UK). The membrane was exposed to anti-TOM20 (mouse, 1:1000; AbCam, Cambridge, UK), anti-VDAC1 (mouse, 1:1000; AbCam, Cambridge, UK), and anti-BNIP3 (rabbit, 1:1000; AbCam, Cambridge, UK) after blocking with a 10% skim milk solution. Following washing, the membrane was incubated with HRP-conjugated anti-rabbit secondary antibody (1:3500; PerkinElmer, MA, SUA) or anti-mouse secondary antibody (1:10000; PerkinElmer, MA, USA). According to the manufacturer’s instructions, the signal was seen using an improved chemiluminescent kit from Amersham Biosciences, and then it was examined using a Molecular Imager VersaDoc MP 4000 (Biorad, Hercules, CA, USA). Proteins were normalized to β-ACTIN (mouse, 1:7000, AbCam, Cambridge, UK) and GAPDH (rabbit, 1:2000, Cell Signaling, Danvers, MA, USA).
+ Open protocol
+ Expand
3

Immunoblot Analysis of MDA-MB-231 Cells After diiodo-squaraine PDT

Check if the same lab product or an alternative is used in the 5 most similar protocols
In Immunoblot analysis, 106 MDA-MB-231 cells were seeded in 100 mm culture dishes and diiodo-squaraine PDT treatment was done as mentioned as earlier and incubated for 24 hours. Cells were lysed using RIPA buffer and quantified using Bradford’s reagent. SDS-PAGE followed by immunoblotting was carried out using 75 μg of total protein and probed using respective antibodies. Then we probed with Horseradish peroxidase(HRP)-conjugated secondary antibodies and detection was done using enhanced chemiluminescence (ECL) method. Images were captured using Molecular Imager VersaDoc MP4000 (Bio-Rad USA) system.
+ Open protocol
+ Expand
4

Western Blot Analysis of SIRT1

Check if the same lab product or an alternative is used in the 5 most similar protocols
6-multiwell plates were seeded with 75x103 cells and incubated overnight. Cells were then treated according to the protocol and then lysed with ice-cold lysis buffer, supplemented with the protease inhibitor cocktail (Roche Molecular Biochemicals, Mannheim, Germany). Cell lysates were then centrifuged at 14000 rpm for 15 minutes at 4° C and the supernatant protein content was determined by the Lowry procedure (Bio-Rad DC Protein Assay, MA, USA).
Equal amount of protein was loaded on a polyacrylamide gel and electrophoretically separated in running buffer. After electrophoresis, the proteins were blotted onto a Hybond-P PVDF membrane (Amersham Biosciences, Buckinghamshire, UK). After blocking with a 10% skim milk solution, the membrane was exposed to the primary antibody anti-SIRT1 (1:250; Sigma-Aldrich, St Louis, MO, USA), and, following overnight incubation, was washed and exposed to HRP-conjugated anti-rabbit secondary antibody (1:3500; PerkinElmer, MA, USA). The signal was visualized with an enhanced chemoluminescent kit (Amersham Biosciences, Buckinghamshire, UK) according to the manufacturer's instructions and analyzed by Molecular Imager VersaDoc MP 4000 (Bio-Rad, Hercules, CA, USA). All the proteins were normalized to calnexin (1:1000; Santa Cruz Biotechnology INC, Santa Cruz, CA, USA).
+ Open protocol
+ Expand
5

Quantifying FVIII Release from Ad-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The capacity of Ad-MSC to release FVIII after endothelial stimulation was assessed by a dot blot assay. Culture media of 7, 14, and 21 days differentiated cells and undifferentiated control were collected and preserved at −80 °C until the time of analysis.
For Dot Blot evaluation, the samples (8 µL) were spotted onto an Immobilon® membrane (Merck-Millipore, Darmstadt, Germany) and allowed to stand for 90 min at RT. The membrane was then saturated for 2 h with PBS, containing 5.0% (w/w) skim milk, and challenged for 2 h with a sheep anti-human FVIII (Affinity Biologicals, Hamilton, ON, Canada) in PBS-skim milk. After washing (3 × 5 mL, for 10 min) with PBS, the membrane was incubated for 2 h with a peroxidase-conjugated donkey anti-sheep IgG (Affinity Biologicals) as the secondary antibody. The membrane was finally stained with the ECL® staining kit (GE-Healthcare, Buckinghamshire, United Kingdom) using a Molecular Imager VersaDoc MP4000 instrument (BioRad, Hercules, CA, USA). For semiquantitative analysis of the protein expression, dot blot densitometry and relative dot intensity were calculated using ImageJ software and normalizing data towards the untreated sample.
+ Open protocol
+ Expand
6

Silybin's Effect on GLUT1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
6-multiwells plates were seeded with a constant number of cells and, following overnight incubation, were exposed to 10-50 µM silybin (Sigma-Aldrich, CAS: 22888-70-6). After 48 hours of treatment, cells were lysed with ice-cold lysis buffer supplemented with the protease inhibitor cocktails (Roche Molecular Biochemicals, Mannheim, Germany). The protein content was determined by Lowry procedure (Bio-rad DC Protein Assay, MA, USA). Equal amounts of protein (15 µg) were loaded on a polyacrylamide gel and electrophoretically separated in running buffer. After electrophoresis, the proteins were blotted onto an Hybond-P PVDF membrane (Amersham Biosciences, Buckinghamshire, UK). After blocking with a 10% skim milk solution, the membrane was exposed to the primary antibody anti-GLUT1 (1:2000; AbCam, Cambridge, UK) and, after washing, it was incubated with HRP-conjugated anti-rabbit secondary antibody (1:3500; PerkinElmer, MA, USA).
The signal was visualized with an enhanced chemoluminescent kit (Amersham Biosciences) according to the manufacturer's instructions and analyzed by Molecular Imager VersaDoc MP 4000 (Bio-Rad, Hercules, CA, USA). GLUT1 was normalized to β-actin (1:7000; AbCam, Cambridge, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!